02:58 , Feb 13, 2016 |  BC Extra  |  Company News

Management tracks

The Association of the British Pharmaceutical Industry named Mike Thompson chief executive, effective March 1. Thompson was SVP of global commercial strategy and platforms at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Cepheid Inc. (NASDAQ:CPHD) promoted COO Warren...
07:00 , May 7, 2015 |  BC Innovations  |  Emerging Company Profile

Twist Bioscience Corp. Corporate Profile

Twist Bioscience Corp. San Francisco, Calif. Technology: Silicon-based DNA synthesis platform Disease focus: Supply/Service Clinical status: Marketed Founded: 2013 by Emily Leproust, Bill Banyai and Bill Peck University collaborators: None Corporate partners: None Number of...
07:00 , Jun 2, 2014 |  BC Week In Review  |  Financial News

Twist Bioscience completes venture financing

Twist Bioscience Corp. , San Francisco, Calif.   Business: Biomanufacturing   Date completed: 5/27/14   Type: Venture financing   Raised: $26 million   Investors: Tao Invest; Arch Venture Partners; Paladin Capital; Asset Management; Applied Materials...
07:00 , Jun 2, 2014 |  BioCentury  |  Finance

Silicon Twist

Silicon Twist Investors in Twist Bioscience Corp. 's $26 million series B round expect the company's 10,000-well silicon platform will enable faster, cheaper and more accurate DNA synthesis than traditional 96-well plastic plates. New investor...
01:23 , May 28, 2014 |  BC Extra  |  Financial News

Twist raises $26 million in series B

Synthetic biology play Twist Bioscience Corp. (San Francisco, Calif.) raised $26 million in a series B round led by new investor Tao Invest. New investors Applied Materials Inc. and NanoDimension and existing investors Arch Venture...